Heparin Stage 2 Interim Revision Announcements
The Stage 2 Heparin monographs (Heparin Sodium and Heparin Sodium Injection) were published as proposed Interim Revision Announcements (IRAs) for public comment in Pharmacopeial Forum (PF) 35(2) March–April 2009. The IRAs were originally targeted to publish in PF 35(4) July–August 2009 as final IRAs and become official August 1, 2009. These IRAs, however, will not be published in PF 35(4) as originally planned.
Once the Stage 2 Heparin monographs have been approved by the B&B Blood and Blood Products Expert Committee, they will be published in PF as final IRAs. These IRAs will be pre-posted on the USP web site on the Heparin Hot Topics page and in the New Official Text section in advance of the print PF to allow more time for manufacturers to implement the new standards. Please watch for further information.